• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Postpartum Depression Market

    ID: MRFR/HC/25983-HCR
    100 Pages
    Rahul Gotadki
    September 2025

    Postpartum Depression Market Research Report By Treatment (Medication, Psychotherapy, Lifestyle Changes, Electroconvulsive Therapy, Transcranial Magnetic Stimulation), By Severity (Mild, Moderate, Severe, Postpartum Psychosis), By Age Group (15-24 years, 25-34 years, 35-44 years, 45 years and above), By Onset (Within 4 weeks postpartum, Between 4 weeks and 12 months postpartum, More than 12 months postpartum), By Risk Factors (History of depression or anxiety, Hormonal changes, Sleep deprivation, Stressful life events, Lack of social support...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Postpartum Depression Market Research Report — Global Forecast till 2034 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Postpartum Depression Market Summary

    The Global Postpartum Depression Market is projected to grow from 15.4 USD Billion in 2024 to 26.6 USD Billion by 2035.

    Key Market Trends & Highlights

    Postpartum Depression Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 5.11 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 26.6 USD Billion, reflecting a substantial increase.
    • In 2024, the market is valued at 15.4 USD Billion, indicating a strong foundation for future growth.
    • Growing adoption of mental health awareness initiatives due to increased societal recognition of postpartum depression is a major market driver.

    Market Size & Forecast

    2024 Market Size 15.4 (USD Billion)
    2035 Market Size 26.6 (USD Billion)
    CAGR (2025-2035) 5.11%

    Major Players

    Sage Therapeutics, Inc., Evotec SE, Teva, Janssen Pharmaceuticals, Sun Pharmaceutical Industries, Takeda Pharmaceutical Company, Mylan, Merck Co, GlaxoSmithKline, Roche Holding, Allergan, Pfizer, Sanofi Aventis, Novartis, Eli Lilly and Company, Reddys Laboratories, Cipla

    Postpartum Depression Market Trends

    The postpartum depression market is rapidly evolving due to increasing awareness and diagnosis rates, advances in treatment options, and government initiatives. Key drivers include the rising prevalence of postpartum depression, growing awareness among healthcare professionals, and the development of effective therapies.Opportunities exist in the exploration of innovative treatments, such as digital therapeutics and remote monitoring, as well as the development of personalized treatment plans.

    Recent trends include an emphasis on early detection and intervention, the integration of mental health services into obstetric care, and the use of technology to improve access to care.The market is expected to continue expanding in the coming years, driven by increasing demand for effective postpartum depression treatments and the growing focus on improving maternal mental health outcomes.

    The increasing recognition of postpartum depression as a critical public health issue underscores the necessity for comprehensive support systems and effective treatment options for new mothers.

    U.S. Department of Health and Human Services

    Postpartum Depression Market Drivers

    Rising Awareness of Mental Health

    The increasing awareness surrounding mental health issues, particularly postpartum depression, plays a crucial role in the Global Postpartum Depression Market Industry. As societal stigma diminishes, more women are encouraged to seek help and treatment. Educational campaigns and healthcare initiatives are actively promoting understanding of postpartum depression, leading to higher diagnosis rates. This heightened awareness is projected to contribute to the market's growth, with estimates suggesting a market value of 15.4 USD Billion in 2024. The focus on mental health is likely to continue influencing healthcare policies, thereby enhancing support systems for new mothers globally.

    Market Segment Insights

    Postpartum Depression Market Treatment Insights  

    The Postpartum Depression Market is segmented by Treatment into Medication, Psychotherapy, Lifestyle Changes, Electroconvulsive Therapy, and Transcranial Magnetic Stimulation. Among these segments, Medication is expected to hold the largest market share, owing to the high prevalence of moderate to severe postpartum depression, which often requires pharmacological intervention. In 2023, the Postpartum Depression Market for Medication was valued at USD 5.2 billion and is projected to reach USD 8.1 billion by 2032, exhibiting a CAGR of 5.6% during the forecast period.Psychotherapy is another significant segment in the Postpartum Depression Market. 

    Psychotherapy involves talk therapy with a mental health professional, such as a psychologist or psychiatrist. It helps women with postpartum depression understand the causes of their condition, develop coping mechanisms, and improve their overall mental well-being. The Postpartum Depression Market for Psychotherapy is expected to grow steadily in the coming years, driven by rising awareness about the importance of mental health and increasing access to mental healthcare services.Lifestyle Changes play a crucial role in managing postpartum depression symptoms. These changes include getting enough sleep, eating a healthy diet, exercising regularly, and engaging in stress-reducing activities.

    Lifestyle Changes are often recommended in conjunction with other treatments, such as Medication or Psychotherapy. 

    The Postpartum Depression Market for Lifestyle Changes is expected to witness moderate growth over the forecast period. Electroconvulsive Therapy (ECT) is a procedure used to treat severe postpartum depression that does not respond to other treatments.ECT involves passing electrical currents through the brain, which can improve mood and reduce symptoms of depression. The Postpartum Depression Market for ECT is expected to remain relatively small but stable over the forecast period. Transcranial Magnetic Stimulation (TMS) is a non-invasive procedure that uses magnetic pulses to stimulate specific areas of the brain.

    TMS is emerging as a promising treatment option for postpartum depression, and the Postpartum Depression Market for TMS is expected to grow significantly in the coming years.

    Postpartum Depression Market Severity Insights  

    The Postpartum Depression Market is divided into severity type, which are Mild, Moderate, Severe, and Postpartum Psychosis. The Mild segment is the largest in 2023 and will remain so throughout the analysis period. The growth of the PPD market can be attributed to the high prevalence of mild symptoms of the condition during the postpartum period. These include mood swings, anxiety, and fatigue, among other symptoms, that are often ignored and dismissed as normal postpartum experiences. The Moderate segment is expected to grow at the highest rate during the review period due to increasing awareness and available treatments for PPD.

    The severe segment includes symptoms such as suicidal thoughts, hallucinations, and extreme changes in appetite. The most serious complication of postpartum depression is PPD, or postpartum psychosis. Mental states, such as hallucinations, delusions, or disorganized thought, characterize postpartum psychosis. It is a very rare, very serious, and very acute illness that should be handled immediately. The incidence of postpartum psychosis grows with the increase in the PPD cases and the number of the same in healthcare settings.

    Postpartum Depression Market Age Group Insights  

    The Postpartum Depression Market is segmented by age group into 15-24 years, 25-34 years, 35-44 years, and 45 years and above. The 25-34 years segment is expected to hold the largest market share in 2023, accounting for around 40% of the total market revenue. This is due to the fact that women in this age group are more likely to experience postpartum depression than women in other age groups. The 15-24 years segment is expected to grow at the fastest rate during the forecast period, with a CAGR of 5.5%.

    This is due to the increasing number of young women giving birth.The 35-44 years segment is expected to grow at a moderate rate during the forecast period, with a CAGR of 4.5%. The 45 years and above segment is expected to grow at the slowest rate during the forecast period, with a CAGR of 3.5%.

    Postpartum Depression Market Onset Insights  

    The onset of postpartum depression can vary significantly, with implications for diagnosis and treatment. Within 4 weeks postpartum, approximately 10-15% of women experience symptoms, known as early-onset postpartum depression. This period is crucial for early detection and intervention, as symptoms can be severe and impact the mother-infant bond. Between 4 weeks and 12 months postpartum, around 5-10% of women develop postpartum depression, classified as late-onset. These cases may be more challenging to diagnose, as symptoms can be more subtle and overlap with other conditions.

    Notably, a significant proportion of women, estimated at around 20%, experience postpartum depression more than 12 months after childbirth. This is known as postpartum depression with late onset and requires specific attention and support, as it can have long-term consequences for both the mother and child. These insights underscore the importance of considering the onset of postpartum depression in market segmentation and developing targeted strategies for prevention, diagnosis, and treatment.

    Postpartum Depression Market Risk Factors Insights  

    The Postpartum Depression Market is segmented into various risk factors, including history of depression or anxiety, hormonal changes, sleep deprivation, stressful life events, and lack of social support. Among these, a history of depression or anxiety is a significant risk factor, with women who have experienced depression or anxiety during pregnancy or in the past being more likely to develop postpartum depression. Hormonal Implants, particularly the rapid decline in estrogen and progesterone levels after childbirth, can also contribute to postpartum depression.Sleep deprivation, a common occurrence in the postpartum period, can exacerbate symptoms of depression. 

    Stressful life events, such as financial difficulties, relationship problems, or a lack of support from family and friends, can also increase the risk of postpartum depression. Finally, lack of social support can lead to feelings of isolation and loneliness, which can further contribute to the development of postpartum depression.

    Get more detailed insights about Postpartum Depression Market Research Report — Global Forecast till 2034

    Regional Insights

    The regional segmentation of the Postpartum Depression Market offers valuable insights into the market's geographical distribution and growth patterns. North America holds a significant market share due to factors such as high awareness of postpartum depression, advanced healthcare infrastructure, and favorable reimbursement policies. Europe follows closely, with a substantial market size attributed to government initiatives, organized screening programs, and research advancements. The APAC region is expected to witness the fastest growth over the forecast period, driven by rising awareness, increasing healthcare expenditure, and government initiatives in countries like China and India.

    South America and MEA also contribute to the global market, with growing awareness and improving healthcare access driving market expansion.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    Major players in Postpartum Depression Market are focusing on developing innovative treatment options and expanding their market presence through strategic partnerships and acquisitions. The Postpartum Depression Market industry is characterized by intense competition among leading Postpartum Depression Market players. These players are investing heavily in research and development to introduce advanced and effective treatment solutions. They are also adopting various strategies such as mergers, acquisitions, and collaborations to strengthen their market position and gain a competitive edge. 

    The Postpartum Depression Market development is driven by increasing awareness about postpartum depression, advancements in treatment approaches, and government initiatives aimed at improving maternal health.Leading Postpartum Depression Market players such as Sage Therapeutics, Inc. have been at the forefront of developing innovative therapies for postpartum depression. The company's Zulresso (brexanolone) injection is the first and only FDA-approved treatment specifically indicated for postpartum depression. Sage Therapeutics, Inc. has established strategic partnerships with leading healthcare providers to expand access to Zulresso and provide comprehensive support to patients. 

    The company is also investing in clinical research to further evaluate the efficacy and safety of brexanolone for the treatment of postpartum depression.Competitor company, Evotec SE, is another prominent player in the Postpartum Depression Market industry. The company is focused on developing novel drug candidates for the treatment of central nervous system disorders, including postpartum depression. Evotec SE has a robust drug discovery platform and a strong track record of successful collaborations with pharmaceutical and biotechnology companies. The company's pipeline includes several promising drug candidates for postpartum depression that are currently in various stages of clinical development.

    Evotec SE is committed to advancing research in postpartum depression and bringing innovative treatment options to patients in need.

    Key Companies in the Postpartum Depression Market market include

    Industry Developments

    • Q3 2023: FDA approves first oral treatment for postpartum depression The U.S. Food and Drug Administration approved Zurzuvae (zuranolone), developed by Sage Therapeutics and Biogen, as the first oral medication for postpartum depression, marking a significant milestone in treatment options for the condition.
    • Q3 2023: Sage Therapeutics and Biogen Announce FDA Approval of ZURZUVAE™ (zuranolone) for Adults with Postpartum Depression (PPD) Sage Therapeutics and Biogen received FDA approval for ZURZUVAE, the first and only oral, once-daily, 14-day treatment specifically indicated for adults with postpartum depression.
    • Q1 2024: Biogen and Sage Therapeutics Announce U.S. Commercial Launch of ZURZUVAE™ (zuranolone) for Postpartum Depression Biogen and Sage Therapeutics announced the U.S. commercial launch of ZURZUVAE, making the first oral treatment for postpartum depression available to patients nationwide.
    • Q2 2024: GH Research Initiates Phase 2 Clinical Trial of GH001 in Postpartum Depression GH Research announced the initiation of a Phase 2 clinical trial evaluating GH001, an investigational therapy, in women with postpartum depression.
    • Q1 2025: Reunion Neuroscience Receives FDA Fast Track Designation for RE104 in Postpartum Depression Reunion Neuroscience announced that the FDA granted Fast Track designation to its investigational drug RE104 for the treatment of postpartum depression, aiming to expedite its development and review.
    • Q1 2025: Lipocine Announces Positive Topline Results from Phase 2 Study of LPCN 1154 in Women with Postpartum Depression Lipocine reported positive topline results from its Phase 2 clinical trial of LPCN 1154, a novel oral therapy candidate for postpartum depression.
    • Q1 2025: Brii Biosciences Announces IND Clearance by FDA for BRII-296 in Postpartum Depression Brii Biosciences announced that the U.S. FDA cleared its Investigational New Drug (IND) application for BRII-296, allowing the company to begin clinical trials in postpartum depression.

    Future Outlook

    Postpartum Depression Market Future Outlook

    The Global Postpartum Depression Market is projected to grow at a 5.11% CAGR from 2024 to 2035, driven by increasing awareness, improved healthcare access, and innovative treatment options.

    New opportunities lie in:

    • Develop digital therapeutics tailored for postpartum mental health.
    • Expand telehealth services to reach underserved populations.
    • Invest in research for personalized treatment approaches based on genetic profiles.

    By 2035, the market is expected to exhibit robust growth, reflecting enhanced treatment accessibility and innovation.

    Market Segmentation

    Postpartum Depression Market Onset Outlook

    • Within 4 weeks postpartum
    • Between 4 weeks and 12 months postpartum
    • More than 12 months postpartum

    Postpartum Depression Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Postpartum Depression Market Severity Outlook

    • Mild
    • Moderate
    • Severe
    • Postpartum Psychosis

    Postpartum Depression Market Age Group Outlook

    • 15-24 years
    • 25-34 years
    • 35-44 years
    • 45 years and above

    Postpartum Depression Market Treatment Outlook

    • Medication
    • Psychotherapy
    • Lifestyle Changes
    • Electroconvulsive Therapy
    • Transcranial Magnetic Stimulation

    Postpartum Depression Market Risk Factors Outlook

    • History of depression or anxiety
    • Hormonal changes
    • Sleep deprivation
    • Stressful life events
    • Lack of social support

    Report Scope

    Report Attribute/Metric Details
    Market Size 2024   15.38 (USD Billion)
    Market Size 2025   16.16 (USD Billion)
    Market Size 2034   25.31 (USD Billion)
    Compound Annual Growth Rate (CAGR)    5.11 % (2025 - 2034)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2024
    Market Forecast Period 2025 - 2034
    Historical Data 2020 - 2024
    Market Forecast Units USD Billion
    Key Companies Profiled Teva, Janssen Pharmaceuticals, Sun Pharmaceutical Industries, Takeda Pharmaceutical Company, Mylan, Merck  Co, GlaxoSmithKline, Roche Holding, Allergan, Pfizer, SanofiAventis, Novartis, Eli Lilly and Company, Dr. Reddys Laboratories, Cipla
    Segments Covered Treatment, Severity, Age Group, Onset, Risk Factors, Regional
    Key Market Opportunities Telehealth services expansion Personalized treatment plans Increased awareness campaigns Smartphonebased monitoring Wearable devices for postpartum depression monitoring
    Key Market Dynamics Increasing prevalence of postpartum depression Growing awareness and screening initiatives Advancements in treatment options Government initiatives and support programs Stigma reduction and increased public discourse
    Countries Covered North America, Europe, APAC, South America, MEA

    FAQs

    What is the projected market size of the Postpartum Depression Market in 2023?

    The Postpartum Depression Market is projected to reach a value of 13.91 billion USD in 2023.

    What is the expected CAGR of the Postpartum Depression Market from 2025 to 2034?

    The Postpartum Depression Market is expected to grow at a CAGR of 5.11% from 2025 to 2034.

    What is the largest regional segment of the Postpartum Depression Market?

    North America is the largest regional segment of the Postpartum Depression Market, accounting for a significant share of the global market.

    What are the key growth drivers of the Postpartum Depression Market?

    Rising awareness about postpartum depression, increasing prevalence of postpartum depression, and growing demand for effective treatments are key growth drivers of the Postpartum Depression Market.

    Who are the major competitors in the Postpartum Depression Market?

    Major competitors in the Postpartum Depression Market include pharmaceutical companies, medical device manufacturers, and healthcare providers.

    What are the major applications of postpartum depression treatments?

    Major applications of postpartum depression treatments include diagnosis, prevention, and treatment of postpartum depression.

    What are the challenges faced by the Postpartum Depression Market?

    Challenges faced by the Postpartum Depression Market include stigma associated with mental health issues, lack of awareness, and limited access to healthcare services.

    What is the expected impact of technological advancements on the Postpartum Depression Market?

    Technological advancements, such as telemedicine and digital health tools, are expected to improve access to care and enhance the overall management of postpartum depression.

    What are the regulatory considerations for the Postpartum Depression Market?

    Regulatory considerations for the Postpartum Depression Market include adherence to ethical guidelines, data privacy, and patient safety regulations.

    What are the emerging trends in the Postpartum Depression Market?

    Emerging trends in the Postpartum Depression Market include personalized treatment approaches, integrated care models, and the use of artificial intelligence for early detection and intervention.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials